Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $5.3100 (-2.93%) ($5.3100 - $5.3100) on Mon. May. 16, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.32% (three month average) | RSI | 37 | Latest Price | $5.3100(-2.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -10.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(46%) IBB(43%) ARKK(42%) ARKG(41%) XAR(39%) | Factors Impacting ATRA price | ATRA will decline at least -2.66% in a week (0% probabilities). VIXM(-41%) VXX(-23%) UNG(-19%) USO(-12%) TLT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.66% (StdDev 5.32%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-18.12(-441.24%) | Resistance Level | $6.52 | 5 Day Moving Average | $5.33(-0.38%) | 10 Day Moving Average | $6(-11.5%) | 20 Day Moving Average | $6.52(-18.56%) | To recent high | -64% | To recent low | 6.4% | Market Cap | $395m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |